Peptone Platform
AI-powered drug discovery platform for peptide therapeutics
Platform · Cloud SaaSCompany source
Company profile
About Peptone
Peptone operates in the drug discovery and development space, applying artificial intelligence and computational approaches to advance therapeutic peptide and biologics research. The company focuses on using modern AI techniques to streamline the traditionally complex and time-consuming process of identifying, designing, and optimizing peptide-based therapeutics. By combining machine learning with biological insights, Peptone aims to reduce development timelines and improve the success rates of novel drug candidates. The company serves pharmaceutical companies, biotechnology firms, and research institutions seeking to accelerate their drug discovery pipelines. Peptone's technology platform addresses key challenges in peptide therapeutics including stability, specificity, and manufacturability, positioning the company at the intersection of AI innovation and biopharmaceutical development.
Company description Peptone official website
Primary marketDrug Discovery & Development
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Peptone?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Biotechnology
- Pharma
- Research
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Small molecule stabilization of diverse amyloidogenic immunoglobulin light chains revealed by hydrogen-deuterium exchange mass spectrometry.Journal of molecular biology · Jun 29, 2026
Transient tertiary structure in intrinsically disordered proteins revealed by multithermal enhanced sampling.Nature communications · May 13, 2026
Molecular model of a bacterial flagellar motor in situ reveals a "parts-list" of protein adaptations to increase torque.bioRxiv : the preprint server for biology · Oct 9, 2024
ADOPT: intrinsic protein disorder prediction through deep bidirectional transformers.NAR genomics and bioinformatics · Jun 1, 2023
pepKalc: scalable and comprehensive calculation of electrostatic interactions in random coil polypeptides.Bioinformatics (Oxford, England) · Jun 15, 2018
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Peptone
Recent articles published on Peptone's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Drug Discovery & Development
Companies using AI, machine learning, or computational biology to discover new drug candidates, identify drug targets, predict drug efficacy, or accelerate pharmaceutical development. Includes both small molecule and biologics development, precision oncology drug discovery, and AI-driven target identification and molecule design.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.